CNRWX
Price
$25.43
Change
+$0.02 (+0.08%)
Updated
Jul 16 closing price
Net Assets
369.07M
GFACX
Price
$70.96
Change
+$0.29 (+0.41%)
Updated
Jul 16 closing price
Net Assets
322.72B
Interact to see
Advertisement

CNRWX vs GFACX

Header iconCNRWX vs GFACX Comparison
Open Charts CNRWX vs GFACXBanner chart's image
City National Rochdale US Cor Eq N
Price$25.43
Change+$0.02 (+0.08%)
VolumeN/A
Net Assets369.07M
American Funds Growth Fund of Amer C
Price$70.96
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets322.72B
CNRWX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CNRWX vs. GFACX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNRWX is a Buy and GFACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 323B vs. CNRWX (369M). CNRWX pays higher dividends than GFACX: CNRWX (0.05) vs GFACX (0.00). CNRWX was incepted earlier than GFACX: CNRWX (13 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than CNRWX (1.07). GFACX is a more actively managed with annual turnover of: 25.00 vs. CNRWX (20.00). CNRWX has a lower initial minimum investment than GFACX: CNRWX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 7.11 vs. CNRWX (-9.04). GFACX return over 5 years is better than : 35.91 vs. CNRWX (31.48).
CNRWXGFACXCNRWX / GFACX
Total Expense Ratio1.071.3679%
Annual Report Gross Expense Ratio1.071.3679%
Fund Existence13 years24 years-
Gain YTD5.39511.29248%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets369M323B0%
Annual Yield % from dividends0.050.00-
Returns for 1 year-9.047.11-127%
Returns for 3 years15.5752.0130%
Returns for 5 years31.4835.9188%
Returns for 10 years85.1763.31135%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.860.06
+3.33%
Inhibikase Therapeutics
MKC71.380.63
+0.89%
McCormick & Company
VTS22.940.06
+0.26%
Vitesse Energy
ADN1.95N/A
N/A
Advent Technologies Holdings Inc.
BTE1.84-0.04
-2.13%
Baytex Energy Corp